Analyst Upgrades

Top Analyst Upgrades and Downgrades: Agilent, Biogen, CB&I, Dick’s, Home Depot, Mylan, Teva and More

The one trend that dominated more than half of the eight-year bull market is that investors have managed to keep finding new reasons to buy stocks after every sell-off. ...
Read Full Story »

How Kala Pharmaceuticals Could Rise 100% to 200%

Kala Pharmaceuticals, Inc. (NASDAQ: KALA) is a recent initial public offering that could come blessed with magical upside if its possibilities blossom into a positive reality. The company is targeting ...
Read Full Story »

Top Analyst Upgrades and Downgrades: CenterPoint, NetApp, NiSource, Nvidia, Orbital ATK, Weyerhaeuser and More

Stocks were indicated to open strong on Monday, with the Dow up almost 100 points and the S&P 500 up about 13 points. Even with the market being just under ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Blue Apron, Edison International, Goldman Sachs, Kohl’s, Nvidia, Perrigo and More

Stocks were indicated to open marginally lower on Friday after some selling pressure emerged this week after the markets kept hitting new highs. Still the one trend that dominated more ...
Read Full Story »

10 Top Stocks Analysts Want You to Sell Now

After weeks of new highs after new highs in the Dow and S&P 500, investors have finally started to see some selling of stocks in August. This has historically not ...
Read Full Story »

Top Analyst Upgrades and Downgrades: BofA, Cerner, Delta Air, Goldman Sachs, JPMorgan, Stratasys, Synacor and More

U.S. stocks and many overseas markets were lower on Thursday amid higher tensions between North Korea and the United States, with S&P 500 futures down about 10 points and Dow ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alcoa, Apple, Netflix, Plains All American, Starbucks, Transocean, Vivint Solar, Vodafone, Walt Disney

Stocks indicated lower on Wednesday, but the Dow and S&P 500 are effectively at all-time highs and have barely pulled back off. Even though this bull market is now well ...
Read Full Story »

Mizuho Reinstates Internet Coverage With 3 Top Picks

The strength shown in the second-quarter earnings reports from Amazon.com Inc. (NASDAQ: AMZN), Alphabet Inc. (NASDAQ: GOOGL) and Facebook Inc. (NASDAQ: FB) may lead an investor to believe one of ...
Read Full Story »

Why One Analyst Sees Tesla Rising Another 25%

Tesla Inc. (NASDAQ: TSLA) has long been the source of much controversy on Wall Street. Fundamentally speaking, how can a company that loses this much money have such a high ...
Read Full Story »

Why Fibrogen Shares Are Exploding

When FibroGen Inc. (NASDAQ: FGEN) released its most recent quarterly results after the markets closed on Monday, it was not the most important news that broke. The firm also updated ...
Read Full Story »

UBS Dividend Ruler Stocks Keep Raising Payouts: 4 to Buy Now

One thing that should be a huge tailwind for investors in the near future is stocks that provide solid total return. With the market priced to perfection, stocks that pay ...
Read Full Story »

Top Analyst Upgrades and Downgrades: FibroGen, Foot Locker, GW Pharma, LendingClub, Lockheed Martin, Tesla, UPS and More

Stocks were indicated marginally lower on Tuesday, but the Dow went above 22,100 and has been up 10 days in a row. August is also supposed to be a bad ...
Read Full Story »

Jefferies Says Tech Has Room to Run: 4 Top Picks to Buy Now

Any way you look at it the market is expensive, but the one counterargument many of the bullish Wall Street analysts and strategists play is a good one. Earnings have ...
Read Full Story »

Jefferies Sees Big Upside From 4 Upcoming Near-Term Biotech Catalysts

If there is one area that can generate riches for speculative investors, it would have to be biotech and emerging pharma. After all, how many companies can go from nothing ...
Read Full Story »

Analyst Says Jump on These 4 Top Stocks on Any Weakness

Often companies will post solid results and investors sell the shares anyway, and that plays right into the time-honored Wall Street axiom of “Buy the rumor, and sell the news.” ...
Read Full Story »